Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Melanoma 25Leukemia, Lymphocytic, Chronic, B-Cell 10Breast Neoplasms 10Recurrence 9Leukemia, Myeloid, Acute 9Carcinoma, Non-Small-Cell Lung 9Neuroblastoma 8Lymphoma, Non-Hodgkin 8Neoplasms 7Ovarian Neoplasms 6Neoplasm Metastasis 6Leukemia 6Colorectal Neoplasms 6Carcinoma, Renal Cell 6Uveal Melanoma 5Myelodysplastic Syndromes 5Multiple Myeloma 5Lymphoma, Follicular 5Lymphoma 5Lung Neoplasms 5Head and Neck Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Lymphoma, B-Cell, Marginal Zone 4Lymphoma, B-Cell 4Hematologic Neoplasms 4Carcinoma, Squamous Cell 4Carcinoma, Hepatocellular 4Uterine Cervical Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3

Interventions

pembrolizumab 3Cyclophosphamide 3fludarabine 2Rosuvastatin Calcium 2Radiotherapy 2Paclitaxel 2Ipilimumab 2Interleukin-2 2Carboplatin 2spartalizumab 1peposertib 1osimertinib 1niraparib 1neotil 1necitumumab 1mirdametinib 1apatinib 1amivantamab 1Valganciclovir 1Tomography, X-Ray Computed 1Rifampin 1Radiation 1Positron-Emission Tomography 1PankoMab-GEX 1Panitumumab 1Nivolumab 1Midazolam 1Metformin 1Magnetic Resonance Imaging 1MEK inhibitor I 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Solid Tumor, Adult × Interleukin-2 × Clear all
NCT04643574 2025-02-14

NeoTIL in Advanced Solid Tumors

Centre Hospitalier Universitaire Vaudois

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT03992326 2021-03-18

Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors

Centre Hospitalier Universitaire Vaudois

Phase 1 Terminated
6 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡